Top 100 Healthcare Aktien Weltweit (nach Marktkapitalisierung)
Die Übersicht zeigt die größten Healthcare Aktien Weltweit nach Marktkapitalisierung.
Die Aktien sind sortiert von groß nach klein mit der größten Marktkapitalisierung auf Platz 1.
Aktie | ISIN | Marktkap. in Mrd. EUR | |||
---|---|---|---|---|---|
#1 | ![]() | Alphabet Inc. C | US02079K1079 | 2.215,55 | |
#2 | ![]() | Alphabet Inc. C | US02079K1079 | 1.475,21 | |
#3 | ![]() | Eli Lilly and | US5324571083 | 759,89 | |
#4 | ![]() | Oracle | US68389X1054 | 479,27 | |
#5 | ![]() | Johnson & Johnson | US4781601046 | 368,31 | |
#6 | ![]() | Novoordisk A/S | US6701002056 | 343,02 | |
#7 | ![]() | AbbVie | US00287Y1091 | 328,10 | |
#8 | ![]() | Salesforce | US79466L3024 | 303,52 | |
#9 | ![]() | Nestle ADR | US6410694060 | 226,40 | |
#10 | ![]() | Philip Morris | US7181721090 | 225,47 | |
#11 | ![]() | AstraZeneca | US0463531089 | 221,73 | |
#12 | ![]() | Abbott Laboratories | US0028241000 | 221,32 | |
#13 | ![]() | General Electric | US3696043013 | 216,03 | |
#14 | ![]() | Blackstone | US09260D1072 | 193,01 | |
#15 | ![]() | Amgen | US0311621009 | 152,73 | |
#16 | ![]() | Boston Scientific | US1011371077 | 150,13 | |
#17 | ![]() | Danaher | US2358511028 | 142,99 | |
#18 | ![]() | Pfizer | US7170811035 | 140,03 | |
#19 | ![]() | General Mills | US3703341046 | 125,40 | |
#20 | ![]() | Palo Alto Networks | US6974351057 | 125,37 | |
#21 | ![]() | Bristol-Myers Squibb | US1101221083 | 109,83 | |
#22 | ![]() | Analog Devices | US0326541051 | 99,84 | |
#23 | ![]() | United Parcel Service | US9113121068 | 94,46 | |
#24 | ![]() | Welltower | US95040Q1040 | 91,71 | |
#25 | ![]() | InfosysADR | US4567881085 | 89,28 | |
#26 | ![]() | MicroStrategy | US5949724083 | 83,66 | |
#27 | ![]() | CVS Health | US1266501006 | 79,01 | |
#28 | ![]() | Zoetis | US98978V1035 | 71,83 | |
#29 | ![]() | GSK | GB00BN7SWP63 | 71,10 | |
#30 | ![]() | JD.com | US47215P1066 | 68,23 | |
#31 | ![]() | Siemens Healthineers | DE000SHL1006 | 64,92 | |
#32 | ![]() | Merck | DE0006599905 | 63,21 | |
#33 | ![]() | Merck | DE0006599905 | 59,54 | |
#34 | ![]() | Compass | GB00BD6K4575 | 58,38 | |
#35 | ![]() | Cloudflare | US18915M1071 | 58,02 | |
#36 | ![]() | Moderna | US60770K1079 | 56,41 | |
#37 | ![]() | Bayer AG | DE000BAY0017 | 51,70 | |
#38 | ![]() | Vertiv Holdings Co | US92537N1081 | 45,07 | |
#39 | ![]() | Haleon | US4055521003 | 44,48 | |
#40 | ![]() | Edwards Lifesciences | US28176E1082 | 42,65 | |
#41 | ![]() | Wipro ADR | US97651M1099 | 35,90 | |
#42 | ![]() | Kraft Heinz | US5007541064 | 34,88 | |
#43 | ![]() | DexCom | US2521311074 | 33,07 | |
#44 | ![]() | General Mills | US3703341046 | 31,69 | |
#45 | ![]() | Baxter | US0718131099 | 29,61 | |
#46 | ![]() | Centene | US15135B1017 | 28,42 | |
#47 | ![]() | BioNTech | US09075V1026 | 27,71 | |
#48 | ![]() | Ventas | US92276F1003 | 27,38 | |
#49 | ![]() | Koninklijke Philips | NL0000009538 | 25,68 | |
#50 | ![]() | Synchrony | US87165B1035 | 24,93 | |
#51 | ![]() | Huntington Bancshares | US4461501045 | 23,73 | |
#52 | ![]() | West Pharmaceutical Services | US9553061055 | 23,69 | |
#53 | ![]() | Rollins | US7757111049 | 23,56 | |
#54 | ![]() | Fresenius SE | DE0005785604 | 20,99 | |
#55 | ![]() | Citizens | US1746101054 | 20,14 | |
#56 | ![]() | Biogen | US09062X1037 | 19,15 | |
#57 | ![]() | KeyCorp | US4932671088 | 18,68 | |
#58 | ![]() | The Carlyle Group | US14316J1088 | 18,31 | |
#59 | ![]() | Fresenius Medical Care | DE0005785802 | 17,87 | |
#60 | ![]() | Teva Pharmaceutical | US8816242098 | 17,75 | |
#61 | ![]() | Sartorius | DE0007165607 | 15,60 | |
#62 | ![]() | Summit Therapeutics | US86627T1088 | 15,34 | |
#63 | ![]() | Doximity | US26622P1075 | 13,77 | |
#64 | ![]() | Healthpeak Properties | US42250P1030 | 13,04 | |
#65 | ![]() | Incyte | US45337C1027 | 12,89 | |
#66 | ![]() | Vivendi | FR0000127771 | 12,75 | |
#67 | ![]() | Avantor | US05352A1007 | 12,55 | |
#68 | ![]() | Viatris Inc. | US92556V1061 | 12,29 | |
#69 | ![]() | Hims & Hers Health Registered (A) | US4330001060 | 12,26 | |
#70 | ![]() | Carl Zeiss Meditec | DE0005313704 | 12,18 | |
#71 | ![]() | General Electric | US3696043013 | 12,06 | |
#72 | ![]() | First Horizon National | US3205171057 | 11,30 | |
#73 | ![]() | Covestro | DE0006062144 | 10,89 | |
#74 | ![]() | Exelixis | US30161Q1040 | 9,34 | |
#75 | ![]() | Raiffeisen Bank | AT0000606306 | 8,65 | |
#76 | ![]() | Pegasystems | US7055731035 | 8,17 | |
#77 | ![]() | UiPath Registered (A) | US90364P1057 | 7,60 | |
#78 | ![]() | Valley National | US9197941076 | 5,58 | |
#79 | ![]() | Asana | US04342Y1047 | 5,29 | |
#80 | ![]() | Main Capital | US56035L1044 | 5,17 | |
#81 | ![]() | Kingsoft Cloud Holdings Ltd | US49639K1016 | 4,79 | |
#82 | ![]() | SpringWorks Therapeutics | US85205L1070 | 4,15 | |
#83 | ![]() | C3.ai | US12468P1049 | 3,95 | |
#84 | ![]() | Sabra Health Care Reit | US78573L1061 | 3,87 | |
#85 | ![]() | Organon & Co | US68622V1061 | 3,76 | |
#86 | ![]() | Fielmann | DE0005772206 | 3,69 | |
#87 | ![]() | Alight | US01626W1018 | 3,58 | |
#88 | ![]() | Redcare Pharmacy NV | NL0012044747 | 3,40 | |
#89 | ![]() | Viking Therapeutics | US92686J1060 | 3,29 | |
#90 | ![]() | Recursion Pharmaceuticals | US75629V1044 | 3,17 | |
#91 | ![]() | Oscar Health Registered (A) | US6877931096 | 3,12 | |
#92 | ![]() | Medical Properties | US58463J3041 | 2,81 | |
#93 | ![]() | Gerresheimer | DE000A0LD6E6 | 2,73 | |
#94 | ![]() | Teladoc Health | US87918A1051 | 2,55 | |
#95 | ![]() | BB Biotech | CH0038389992 | 2,33 | |
#96 | ![]() | Clover Health Investments Registered (A) | US18914F1030 | 2,15 | |
#97 | ![]() | Sinch | SE0016101844 | 2,14 |
Anzeige
x
Aktuelle Nachrichten zu den Top-Aktien
Eli Lilly-Aktie: Das ist eine Enttäuschung!
Die Eli Lilly-Aktie sackte am gestrigen Dienstag um über sechs Prozent auf ein neues Jahrestief ab. Womit hat der US-Pharmariese...
WeiterlesenOracle-Aktie: Das ist der Hit!
Gerade in Europa sind die Anforderungen an den Datenschutz in den letzten Jahren drastisch gestiegen. Kein Wunder also, dass der...
WeiterlesenPfizer-Aktie Prognose: Sollten Sie jetzt kaufen?
Der US-Pharmakonzern Pfizer überraschte im vierten Quartal mit positiven Ergebnissen. Am 6. Februar bekräftigte das Unternehmen seine Erwartungen für das...
Weiterlesen